Abstract：Objective To further explore the genetic association between rs324011 of STAT6 and asthma susceptibility through Meta-analysis. Methods Literature search was performed in PubMed, EMBASE, CNKI and Wanfang Database till the date of December 2016. Odds ratio (OR) and 95% confidence interval (95%CI) were calculated to assess the strength of association between rs324011 and asthma. Results A total of 9 studies comprising 2247 cases and 2940 controls were included in our analysis. Significant associations between rs324011 and asthma were observed that TT genotype might increase the risk of asthma in recessive model and additive model (OR=1.32, 95%CI 1.10-1.58, P=0.003 for TT vs CC+CT; OR=1.34, 95%CI 1.10-1.63, P=0.004 for TT vs CC). No similar association was observed in other models. Conclusion The polymorphism rs324011 in STAT6 is a susceptibility loci of asthma. TT genotype may increase the risk of asthma, especially in the Caucasian population.
[1] Vercelli D. Discovering susceptibility genes for asthma and allergy [J]. Nat Rev Immunol，2008，8（3）：169-182.
[2] Daniels SE，Bhattacharrya S，James A，et al. A genome-wide search for quantitative trait loci underlying asthma [J]. Nature，1996，383（6597）：247-250.
[3] Takeda K，Kishimoto T，Akira S. STAT6：its role in interleukin 4-mediated biological functions [J]. J Mol Med （Berl），1997，75（5）：317-326.
[4] Elias JA，Lee CG，Zheng T，et al. New insights into the pathogenesis of asthma [J]. J Clin Invest，2003，111（3）：291-297.
[5] Berenguer AG，Fernandes AT，Oliveira S，et al. Genetic polymorphisms and asthma：findings from a case-control study in the Madeira island population [J]. Biol Res，2014， 47：40.
[6] Li J，Lin LH，Wang J，et al. Interleukin-4 and interleukin-13 pathway genetics affect disease susceptibility，serum immunoglobulin E levels，and gene expression in asthma [J]. Ann Allergy Asthma Immunol，2014，113（2）：173-179.
[7] Al-Muhsen S，Vazquez-Tello A，Jamhawi A，et al. Association of the STAT-6 rs324011（C2892T）variant but not rs324015（G2964A），with atopic asthma in a Saudi Arabian population [J]. Hum Immunol，2014，75（8）：791-795.
[8] Godava M，Kopriva F，Bohmova J，et al. Association of STAT6 and ADAM33 single nucleotide polymorphisms with asthma bronchiale and IgE level and its possible epigenetic background [J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub，2012，156（3）：236-247.
[9] Kavalar MS，Balantic M，Silar M，et al. Association of ORMDL3，STAT6 and TBXA2R gene polymorphisms with asthma [J]. Int J Immunogenet，2012，39（1）：20-25.
[10] Wu X，Li Y，Chen Q，et al. Association and gene-gene interactions of eight common single-nucleotide polymorphisms with pediatric asthma in middle china [J]. J Asthma，2010，47（3）：238-244.
[11] Daley D，Lemire M，Akhabir L，et al. Analyses of associations with asthma in four asthma population samples from Canada and Australia [J]. Hum Genet，2009，125（4）：445-459.
[12] Kabesch M，Schedel M，Carr D，et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma [J]. J Allergy Clin Immunol，2006，117（2）：269-274.
[13] Pykalainen M，Kinos R，Valkonen S，et al. Association analysis of common variants of STAT6，GATA3，and STAT4 to asthma and high serum IgE phenotypes [J]. J Allergy Clin Immunol，2005，115（1）：80-87.
[14] Hirota T，Takahasi A，Kubo M，et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population [J]. Nature Genetics，2011，43（9）：893-896.
[15] Wang X，Li Y，Luo D，et al. Lyn regulates mucus secretion and MUC5AC via the STAT6 signaling pathway during allergic airway inflammation [J]. Sci Rep，2017，7：42675.
[16] Antczak A，Domanska A，Gorski P，et al. Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma [J]. Int J Immunopathol Pharmacol，2016，29（2）：195-204.
[17] Schedel M，Frei R，Bieli C，et al. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding，STAT6 promoter activity，and mRNA expression [J]. J Allergy Clin Immunol，2009，124（3）：583-589.
[18] McKenzie AN. Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13 [J]. Pharmacol Ther，2000，88（2）：143-151.
[19] Liu Y，Zhang H，Ni R，et al. IL-4R suppresses airway inflammation in bronchial asthma by inhibiting the IL-4/STAT6 pathway [J]. Pulm Pharmacol Ther，2017，43：32-38.
[20] Kuperman DA，Schleimer RP. Interleukin-4，interleukin-13，signal transducer and activator of transcription factor 6，and allergic asthma [J]. Curr Mol Med，2008，8（5）：384-392.
[21] Miyata S，Matsuyama T，Kodama T，et al. STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells [J]. Clin Exp Allergy，1999，29（1）：114-123.
[22] Kim S，Hong J，Lee J，et al. 18β-Glycyrrhetinic acid，the major bioactive component of Glycyrrhizae Radix，attenuates airway inflammation by modulating Th2 cytokines，GATA-3，STAT6，and Foxp3 transcription factors in an asthmatic mouse model [J]. Environ Toxicol Pharmacol，2017，52：99-113
[23] Hoppenot D，Malakauskas K，Lavinskiene S，et al. p-STAT6，PU.1，and NF-κB are involved in allergen-induced late-phase airway inflammation in asthma patients [J]. BMC Pulm Med，2015，15：122.
[24] Duetsch G，Illig T，Loesgen S，et al. STAT6 as an asthma candidate gene：polymorphism-screening，association and haplotype analysis in a Caucasian sib-pair study [J]. Hum Mol Genet，2002，11（6）：613-621.
[25] Jeon J，Ko S，Kim Y，et al. The flavone eupatilin inhibits eotaxin expression in an NF-κB-dependent and STAT6-independent manner [J]. Scand J Immunol，2015，81（3）：166-176.
2017, Vol. 14 
京公网安备 11010502046598号